In this episode, Psychedelic Spotlights, Director of Content, Jill Ettinger sits down with Chief Executive Officer, Director, and Co-Founder of Novamind, Yaron Conforti.
Similar Posts
My 5-MeO-DMT Psychedelic Experience in Tepotzlan Mexico | Tandava Retreats
In this short vlog, Swati Sharma, Media Director of PsychedelicSpotlight.com…
Interview with Dr. Erica Zelfand
This week on the Psychedelic Spotlight podcast, we’re chatting with Dr. Erica Zelfand. She is a family doctor specializing in integrative and functional family medicine. She’s also a ketamine prescriber, facilitator of therapeutic experiences, and a medical writer and public speaker.
Important Correction for MindMed Trials (Plus Changes In MMED/MMEDF’S Timelines)
What’s up Psychedelic Investors? In today’s episode entitled :Important Correction for MindMed Trials (Plus Changes In MMED/MMEDF’S Timelines), we discuss a correction I have to make to my MindMed (MMED / MMEDF) coverage regarding their clinical trials treating addiction with 18MC, and ADHD with LSD microdoses. The start dates for these phase 2a trials have been postponed until the third quarter of 2021, and have not yet started.
MindMed is the leader in psychedelic medicines, and is my top Psychedelic Stock. Is MindMed a buy? Is MindMed a good Investment? Watch our channel to find out!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media!
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MMED #MMEDF
Interview With Michelle Janikian, Author, Host & Editor at Psychedelics Today
Michelle opens up about how her work as a cannabis writer led her down the path of psychedelics, her interest in safe magic mushroom use and why she was compelled to write her guidebook Your Psilocybin Mushroom Companion.